Swiss food giant Nestle has acquired CM&D Pharma, a UK-based drug maker that specialises in the development of products tailored for patients with kidney disease, for an undisclosed amount.
The company now plans to bet on health sciences, skin care and specialised products, says Arnab Dutta.
Can Nestle go beyond Maggi? While recovery in the March quarter has been led by the popular noodle brand, the company hopes for a different revenue mix in five years.
Names such as Danone, Dabur, Mondelez and Abbott Healthcare have also figured on the list of suitors.
This time food regulators found excess presence of ash content in Maggi
Experts question Nestle's silence over Maggi controversy.
Although the BJP has never been ballistic about the BJD and Narendra Modi has avoided being critical of Naveen Patnaik, the BJP is optimistic that the party can improve its electoral fortunes in Odisha on its own, notes Rup Narayan Das.
In 2019, the growth in sales of the Maggi brand of products surpassed the pre-ban level of 2014, in terms of both volume and value. While, Nestle raised prices of Maggi products by an average 3.1 per cent, its volume rose by 9.6 per cent year-on-year.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Horlicks widens brand appeal in increasingly competitive market.
Brand ambassadors and their lackeys are busy opposing the idea of being held accountable, even though they are ready to take all the money, says Sunita Narain.
Punishing brand ambassadors shows that the government is only interested in going after the low hanging fruit, says Tanmaya Nanda.
Nestl is facing its worst crisis ever. Can it learn from its peers?
Coca-Cola's acquisition of British coffee chain Costa, its biggest acquisition of a brand in history, faces three challenges in India.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances